Global Prosthetic Heart Valves Market is expected to foresee significant growth. North America to lead the growth!

Global prosthetic heart valves market is expected to register a CAGR of approx. 11% over the period of 2022-2028. A prosthetic heart valve is a surgically implanted artificial device used to replace damaged heart valves caused by heart valve diseases. Heart valves aid in the regulation of blood flow through the heart. Inadequate blood flow is caused by a malfunctioning heart valve, necessitating later prosthetic heart valve surgery. The global prosthetic heart valve market is rising due to the growing number of people suffering from heart valvular diseases. Some novel advancement in the making of the heart valve is increasing which is likely to aid the growth of the prosthetic heart valve market. For instance,in March 2021, the U.S. FDA approved the Harmony TPV (Transcatheter Pulmonary Valve) System for the treatment of adult and pediatric patients having a native or surgically repaired RVOT (right ventricular outflow tract). Owing to these glaring statistics the demand for prosthetic heart valves is anticipated to grow in the forthcoming years as their chances of recovery after surgery are very high and they are harmless. Moreover, the availability of computational tools allows for accurate valvar disease detection, which leads to proper treatment fueling the demand for the prosthetic heart valve market. Furthermore, the growing demand for minimally invasive surgeries is expected to drive the market for prosthetic heart valve market in the coming years.

For a detailed analysis of the Global Prosthetic Heart Valves Market browse through – https://univdatos.com/report/prosthetic-heart-valves-market/

Based on the types of valves, the prosthetic heart valve market is segmented into transcatheter heart valve, tissue heart valve, and mechanical heart valve. The transcatheter heart valve segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe because of an increase in cardiovascular disease and a rise in demand for cardiac valve replacement therapy.

Based on diseases, the market is fragmented into aortic valve diseases, mitral valve diseases, and pulmonary valve diseases. the aortic valve disease segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. This increase is mainly due to the high prevalence of AVD, which is the most common valvular heart disease worldwide.

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=28672

For a better understanding of the market adoption of prosthetic heart valves market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the prosthetic heart valve industry owing to the rise in medical expertise, new product launches, and government regulations that provide favorable reimbursement scenarios.

Some of the major players operating in the market include Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, Artivion Inc, Braile Biomédica, Colibri Heart Valve LLC, JenaValve Technology Inc, Micro Interventional Devices Inc.

Global Prosthetic Heart Valves Market Segmentation

Market Insight, by Types of Valves

• Transcatheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve

Market Insight, by Diseases

• Aortic Valve Disease
• Mitral Valve Disease
• Pulmonary Valve Disease

Market Insight, by End Users

• Hospitals
• Ambulatory Surgical Centers
• Others

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Australia
  • Japan
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Edwards Lifesciences Corporation
• Medtronic plc.
• Boston Scientific Corporation
• Abbott Laboratories
• LivaNova PLC
• Artivion Inc
• Braile Biomédica
• Colibri Heart Valve LLC
• JenaValve Technology Inc
• Micro Interventional Devices Inc.